[go: up one dir, main page]

WO2011126199A1 - Surfactants for water dispersing of nanoparticles - Google Patents

Surfactants for water dispersing of nanoparticles Download PDF

Info

Publication number
WO2011126199A1
WO2011126199A1 PCT/KR2010/008588 KR2010008588W WO2011126199A1 WO 2011126199 A1 WO2011126199 A1 WO 2011126199A1 KR 2010008588 W KR2010008588 W KR 2010008588W WO 2011126199 A1 WO2011126199 A1 WO 2011126199A1
Authority
WO
WIPO (PCT)
Prior art keywords
nanoparticles
water
surfactant
chemical formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/008588
Other languages
French (fr)
Inventor
Sang Wook Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajou University Industry Academic Cooperation Foundation
Original Assignee
Ajou University Industry Academic Cooperation Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajou University Industry Academic Cooperation Foundation filed Critical Ajou University Industry Academic Cooperation Foundation
Publication of WO2011126199A1 publication Critical patent/WO2011126199A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds

Definitions

  • the magnetic nanoparticles made water-soluble may be utilized for magnetic resonance imaging (MRI).
  • MRI magnetic resonance imaging
  • step (c) the halogen of the compound represented by Chemical Formula 7 is substituted with the compound represented by Chemical Formula 5, thereby resulting in a non-toxic surfactant for dispersing nanoparticles in water.
  • step (c) may be repeated several times. It is because the substitution with the compound represented by Chemical Formula does not occur easily if the compound represented by Chemical Formula 4 has a long alkyl chain and thus is strongly nonpolar.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

A surfactant capable of stably dispersing nanoparticles in water is disclosed. The disclosed surfactant is capable of stably dispersing a variety of nanoparticles in water while maintaining their physical properties. It is applicable to various nanoparticles such as metals, metal oxides, quantum dots, and so forth.

Description

SURFACTANTS FOR WATER DISPERSING OF NANOPARTICLES
The present disclosure relates to a surfactant capable of stably dispersing nanoparticles in water.

Nanoparticles have a high surface area to volume ratio and exhibit properties quite different from those of the bulk material due to the quantum confinement effect [Alivisatos, A. P. Science, 271: 933 (1996)]. Among various nanoparticles, fluorescent quantum dots and magnetic iron oxide nanoparticles may be used for biological imaging applications. For this, the nanoparticles need to have uniform size and be water-soluble [Gao, X. et al., S. Nat. Biotechnol., 22: 969-976 (2004); Bruchez, J. M. et al., A. P. Science, 281: 2013-2016 (1998); Chan, W. C. W. et al., S. Science, 281: 2016-2018 (1998); and Weissleder, R. et al., L. Nat. Biotechnol., 23: 1418 (1998)]. In this context, the most pertinent way may be to produce the nanoparticles in water. However, it is impossible to form uniform nanoparticles in water with the synthesis method known thus far. As for the quantum dots, they give too low a quantum yield when they are synthesized in water, making them inapplicable to actual imaging. Also, there is no case of producing uniform iron oxide nanoparticles in water reported.
Accordingly, in general, the process of synthesizing uniform quantum dots or iron oxide nanoparticles in an organic solvent and then transferring them to water is required.
Recently, synthesis techniques for uniform quantum dots such as cadmium selenide (CdSe) and cadmium telluride (CdTe) and magnetic nanoparticles such as iron oxide, iron-platinum (FePt) and cobalt have been developed, and several surfactants for making them water-soluble have been reported.
In order to water-soluble quantum dots, water-soluble polymers, lipids or thiol ligands such as thiol dendrimers and dithiols have been used. Further, 4-(dimethylamino)pyridine has been used to transfer various metal nanoparticles to the water phase. For iron oxide, Weissleder et al. could dissolve iron oxide nanoparticles of various sizes in water using dextran and used them for magnetic resonance imaging (MRI). In addition, use of a polymer having a cyclodextran or maleic anhydride backbone to dissolve various nanoparticles in water has been reported.
Although a surfactant capable of dissolving iron oxide, quantum dots and various metals in water was reported, there remains the problem of quantum yield and stability.
As for the quantum dots, if the quantum yield in an organic solvent is 50%, dissolution of them in water using a surfactant results in a yield only about 50 to 60% of that in the organic solvent (i.e. the final yield is only 25 to 30%).
As for the iron oxide nanoparticles, there are few researches about solubilization in water in spite of the necessity. In most cases, phospholipids or dextrans have been used to form vesicles and thereby dissolve them in water. However, in this case, aggregation may occur at low concentrations. This phenomenon is more distinct with magnetic nanoparticles probably because of stronger attractions between them than other nanoparticles.

The inventors have worked to improve quantum yield and stability of nanoparticles in water. As a result, they have developed a novel surfactant for dispersing in water and found out that, when the novel surfactant for dispersing in water is used, a variety of nanoparticles may be stably dispersed in water without aggregation and solvent replacement is possible at room temperature, thereby overcoming the quantum yield problem for quantum dots.
Thus, the present disclosure is directed to providing a novel surfactant for dispersing nanoparticles in water capable of solving the quantum yield and stability problems of the nanoparticles.

In an aspect, the present disclosure provides a surfactant for dispersing nanoparticles in water represented by Chemical Formula 1:
Figure PCTKR2010008588-appb-I000001
(1)
wherein n is from 1 to 500; R1 is C1-C30 alkyl; R2 is hydrogen or C1-C50 alkyl; and R3 is hydrogen or C1-C30 alkyl.

The surfactant for dispersing nanoparticles in water according to the present disclosure is capable of stably dispersing a variety of nanoparticles in water while maintaining their physical properties. Hence, it will be widely applicable to various nanoparticles including metals, metal oxides, quantum dots, and so forth.
The quantum dots made water-soluble using the surfactant according to the present disclosure may be introduced into an organism to monitor biological metabolisms or diagnose various diseases including cancer macroscopically, and may be introduced into cells to study various cellular mechanisms microscopically. Since the surfactant can be synthesized in large scale very economically, it will be able to replace the expensive phospholipids currently used to obtain water-soluble nanoparticles.
In addition, the magnetic nanoparticles made water-soluble may be utilized for magnetic resonance imaging (MRI).
The above and other objects, features and advantages of the present disclosure will become apparent from the following description of certain exemplary embodiments given in conjunction with the accompanying drawings, in which:
Fig. 1 shows a result of measuring hydrated radius by gel-filtration chromatography (left) and light scattering (right);
Fig. 2 schematically illustrates the transfer of nanoparticles from a dichloromethane (MC) solvent to water using a surfactant (top) and the transfer of nanoparticles to water using oleic acid, oleylamine or trioctylphosphine (TOP)/trioctylphosphine oxide (TOPO) as a stabilizer (bottom);
Fig. 3 shows MALDI-TOF analysis result of polyethylene glycol methyl ether (mPEG, Mn = 2000), an intermediate and a final product, from top to bottom;
Fig. 4 shows 1H NMR analysis result of an intermediate (top) and a final product (bottom);
In Fig. 5, (a) shows Fe2O3 nanoparticles dissolved in hexane, (b) shows Fe2O3 nanoparticles dispersed in water using a surfactant (using mPEG with Mn = 5000) according to an embodiment of the present disclosure, (c) shows Fe2O3 nanoparticles dispersed in water using a surfactant (using mPEG with Mn = 2000) according to another embodiment of the present disclosure, (d) shows Fe2O3 nanoparticles dispersed in water using a surfactant (using mPEG with Mn = 750) according to another embodiment of the present disclosure, (e) shows Fe2O3 nanoparticles dispersed in water using a di(mPEG)-monoalkyl type surfactant, and (f) shows Fe2O3 nanoparticles dispersed in water using a mono(mPEG)-dialkyl type surfactant;
Fig. 6 shows nanoparticles dissolved in hexane (left) or in water (right) [(a) shows CdSe/ZnS nanoparticles observed under UV light (The image inserted at the left bottom shows the nanoparticles observed under visible light, and the image inserted at the right bottom is a TEM image of the nanoparticles in water.), (b) shows InP/ZnS nanoparticles (The graph inserted at the right bottom shows fluorescence intensity of the nanoparticles in hexane and water.), (c) shows Au nanoparticles (The image inserted at the right top is a TEM image of the nanoparticles, and the graph inserted at the left bottom shows absorbance of the nanoparticles in water (red) or hexane (blue).), and (d) shows Fe2O3 nanoparticles (The image inserted at the left top is a TEM image of the nanoparticles in water, and the image inserted at the right bottom shows the nanoparticles in water under a magnetic field).];
Fig. 7 shows nanoparticles used as a magnetic resonance imaging (MRI) imaging agent dispersed in water using a surfactant according to an embodiment of the present disclosure (It can be seen that the role as the MRI imaging agent is retained.);
Fig. 8 shows absorption spectrum of Au nanoparticles synthesized in an organic solvent and then dispersed in water; and
Fig. 9 shows CdSe/ZnS, InP/ZnS, Au and Fe2O3 nanoparticles, from left to right, dispersed in hexane (left), and the nanoparticles dispersed in water using a surfactant according to an embodiment of the present disclosure (right) (In each image, the lower layer is a water layer and the upper layer is a hexane layer.).

Hereinafter, the embodiments of the present disclosure will be described in detail with reference to accompanying drawings.
The present disclosure relates to a novel surfactant for dispersing nanoparticles in water, more particularly to a surfactant for dispersing nanoparticles in water represented by Chemical Formula 1:
Figure PCTKR2010008588-appb-I000002
(1)
wherein n is from 1 to 500; R1 is C1-C30 alkyl; R2 is hydrogen or C1-C50 alkyl; and R3 is hydrogen or C1-C30 alkyl.
In the context of the present disclosure, the nanoparticles refer to general nanoparticles, for example, metals such as gold (Au) and palladium (Pd), magnetic oxides such as Fe2O3 and Fe3O4 or quantum dots such as CdSe, InP/ZnS and CdSe/ZnS core-shell nanoparticles.
The surfactant represented by Chemical Formula 1 may be synthesized using compounds represented by Chemical Formulae 2 to 7 according to Scheme 1.
Figure PCTKR2010008588-appb-I000003
(2)
Figure PCTKR2010008588-appb-I000004
(3)
Figure PCTKR2010008588-appb-I000005
(4)
Figure PCTKR2010008588-appb-I000006
(5)
Figure PCTKR2010008588-appb-I000007
(6)
Figure PCTKR2010008588-appb-I000008
(7)
[Scheme 1]
Figure PCTKR2010008588-appb-I000009
In Chemical Formulae 2 to 7 and Scheme 1, n is from 1 to 500; R1 is C1-C30 alkyl; R2 is hydrogen or C1-C30 alkyl; R3 is hydrogen or C1-C30 alkyl; and X is F, Cl, Br or I.
The surfactant for dispersing nanoparticles in water represented by Chemical Formula 1 may be prepared by a process including:
(a) reacting a compound represented by Chemical Formula 2 with a compound represented by Chemical Formula 3 at 10 to 200 ºC for 1 to 24 hours to prepare a compound represented by Chemical Formula 6;
(b) reacting the resulting compound represented by Chemical Formula 6 with a compound represented by Chemical Formula 4 at 10 to 200 ºC for 0.5 to 48 hours to prepare a compound represented by Chemical Formula 7; and
(c) reacting the resulting compound represented by Chemical Formula 7 with a compound represented by Chemical Formula 5 at 10 to 200 ºC for 1 to 48 hours:
All the reactions in the above steps are nucleophilic substitution reactions.
First, in the compound represented by Chemical Formula 2 of the step (a), X may be a halogen element such as F, Cl, Br or I. Specifically, it may be Cl.
In the compound represented by Chemical Formula 3, R1 may be C1-C30 alkyl. Specifically, it may be C1-C5 alkyl. For example, the compound represented by Chemical Formula 3 may be methoxy-PEG, ethoxy-PEG, or the like. And, n may be from 1 to 500, specifically from 10 to 200.
In the step (a), the compound represented by Chemical Formula 2 may be added in excess to achieve 1 : 1 reaction. Otherwise, the compound represented by Chemical Formula 3 may be substituted with the compound represented by Chemical Formula 2 two or more times and the reaction may not proceed to the next step.
In the compound represented by Chemical Formula 4 of the step (b), R2 may be hydrogen or C1-C50 alkyl. Specifically, it may be C1-C20 alkyl. For example, the compound represented by Chemical Formula 4 may be hexadecylamine (HDA), octadecylamine (ODA), or the like.
In the compound represented by Chemical Formula 5 of the step (c), R3may be hydrogen or C1-C30 alkyl. Specifically, it may be C1-C5 alkyl. For example, the compound represented by Chemical Formula 5 may be methanol, ethanol, isopropanol, butanol, or the like.
In the step (c), the halogen of the compound represented by Chemical Formula 7 is substituted with the compound represented by Chemical Formula 5, thereby resulting in a non-toxic surfactant for dispersing nanoparticles in water.
In order to substitute the compound represented by Chemical Formula 7 with the compound represented by Chemical Formula 5 to a higher degree, the step (c) may be repeated several times. It is because the substitution with the compound represented by Chemical Formula does not occur easily if the compound represented by Chemical Formula 4 has a long alkyl chain and thus is strongly nonpolar.
All the reactions in the above steps are carried out at 30 to 60 ºC under nitrogen atmosphere. It is because the moisture included in the air may act as a nucleophile and interfere with the reactions. In the reactions, an aprotic solvent such as tetrahydrofuran (THF) may be used.
Unlike other surfactants for dispersing in water, the surfactant for dispersing nanoparticles in water prepared in accordance with the present disclosure allows solvent replacement at room temperature. Although quantum dots generally experience decrease in quantum yield when they are transferred from an organic solvent to water, due to heating at high temperature, the surfactant according to the present disclosure experiences little change in quantum yield since the solvent can be replaced at room temperature.

The examples and experiments will now be described. The following examples and experiments are for illustrative purposes only and not intended to limit the scope of the present disclosure.
Example 1: Preparation ofsurfactant for dispersing nanoparticles in water
Dried polyethylene glycol methyl ether (mPEG, Mn = 2000, 2 g, 1 mmol) and POCl3 (0.5 mL) were dissolved in anhydrous THF (20 mL) in a 250 mL flask. Then, reaction was performed at 40 ºC for 12 hours. 1 mmol of mPEG was reacted with 5 mmol of POCl3 in order to achieve 1:1 reaction. In order to remove unreacted POCl3 and HCl resulting from the reaction, the reaction mixture was dried in vacuum at 40 ºC for 2 hours and then dissolved in anhydrous THF (15 mL).
Hexadecylamine (HDA, 0.241 g, 1 mmol) was dried in vacuum at 120 ºC for 2 hours, dissolved in THF (3 mL), and then added to the 250 mL flask containing the reaction mixture. After reaction for 24 hours, HCl and THF were removed by drying in vacuum for 2 hours. Then, addition of MeOH (5 mL), reaction at 60 ºC for 1 hour and removal of MeOH was repeated 3 times to accomplish complete substitution with MeOH. It is because, since the alkyl chain of HDA is nonpolar, a complete substitution with MeOH is not easy. Finally, in order to remove HCl, ethylenediamine (EDA, 1 mL) was added and stirred for 30 minutes to form salt. Then, THF and EDA were removed by drying in vacuum. After dissolving in dichloromethane (MC), which is less polar than THF, HCl salt was removed by centrifugation and only the final product dissolved in the supernatant was collected. Structure analysis was carried out by 31P NMR, 1H NMR and MALDI-TOF.
The reaction procedure is summarized in Scheme 2 below. MALDI-TOF result is shown in Fig. 3, and 1H NMR result is shown in Fig. 4. Fig. 3 shows MALDI-TOF analysis result of mPEG (Mn = 2000), an intermediate formed from the reaction of mPEG with POCl3and a final product, from top to bottom. The shift of mass peaks reveals that the substitution reaction occurred successfully. In the early stage of the reaction, mono-mPEG-substituted intermediate was produced because POCl3 was used in excess of mPEG. In the later stage of the reaction, only monoalkyl-substituted, not dialkyl-substituted, intermediate was produced, because of low reactivity of Cl.
1H NMR analysis result of the final product shown in Fig. 4 confirms the presence of mono-mPEG- and monoalkyl-substituted compounds. The ethylene peak of mPEG was observed at 3.6 ppm and the terminal -OCH3 peak of mPEG was identified at 3.382 ppm. The three broad peaks at 1.76 ppm, 1.23 ppm and 0.88 ppm are due to -CH2NHP-, -CH2- and terminal -CH3 of HDA.
31P NMR data also confirms the successful reaction.
[Scheme 2]
Figure PCTKR2010008588-appb-I000010
Example 2: Comparison of performance of surfactant for dispersing nanoparticles in water depending on molecular weight ofmPEG
In order to find a surfactant for dispersing nanoparticles in water with optimized performance, experiment was carried out while changing the molecular weight of mPEG. Performance of the surfactants synthesized using mPEG with a molecular weight of 750, 2000 and 5000 was compared. For mPEG with a molecular weight of 750 (mPEG 750), the surfactant was synthesized by dissolving dried mPEG (Mn = 750, 0.75 g, 1 mmol) and POCl3 (0.5 mL) in anhydrous THF (10 mL) in a 250 mL flask and reacting at room temperature for 12 hours, with the remaining procedure being identical to that of Example 1. For mPEG with a molecular weight of 2000 (mPEG 2000), the surfactant was synthesized in the same manner as Example 1. For mPEG with a molecular weight of 5000 (mPEG 5000), the surfactant was synthesized by dissolving dried mPEG (Mn = 5000, 5 g, 1 mmol) and POCl3 (0.5 mL) in anhydrous THF (20 mL) in a 250 mL flask and reacting at 60 ºC for 12 hours, with the remaining procedure being identical to that of Example 1. Fe2O3nanoparticles of the same amount (5 equivalents) were mixed in dichloromethane with each of the surfactants. After completely evaporating the solvent at room temperature for 15 to 20 minutes, the remaining mixture was dispersed again in water. The nanoparticles were dispersed well in water when mPEG 5000 or mPEG 2000 was used. But, they were not dispersed well when mPEG 750 was used.
The result is shown in Fig. 5 [(b) Mn = 5000, (c) Mn = 2000, (d) Mn = 750].
The Fe content in each sample was measured using inductively coupled plasma (ICP). The contents were 0.203 mg/mL, 0.148 mg/mL and 0.010 mg/mL for (b), (c) and (d), respectively. I.e., the amount of the Fe2O3 nanoparticles dispersed in water increased as the molecular weight of mPEG increased. Thus, it can be concluded that a long hydrophilic group is required to disperse nanoparticles in water.
Comparison of performance of surfactant for dispersing nanoparticles in water depending on molecular weight of mPEG
Molecular weight of mPEG Fe content measured using ICP (mg/mL)
Mn = 5000 0.203
Mn = 2000 0.148
Mn = 750 0.010

Example 3:Comparison of performance of surfactant for dispersing nanoparticles in waterdepending on structure
In order to study the performance depending on the surfactant structure, di(mPEG)-monoalkyl and mono(mPEG)-dialkyl type surfactants were synthesized and tested, rather than the common mono(mPEG)-monoalkyl-substituted surfactant. mPEG 2000 was used and each surfactant was prepared in the same manner as Example 1. Fe2O3nanoparticles of the same amount (5 equivalents) were mixed in dichloromethane with each of the surfactants. After completely evaporating the solvent at room temperature for 15 to 20 minutes, the remaining mixture was dispersed again in water.
The result is shown in Fig. 5 (c), (e) and (f). (e) and (f) showed very poor ability to disperse the nanoparticles in water.
Comparison of performance of surfactant for dispersing nanoparticles in water depending on structure
Surfactant structure Ability to disperse nanoparticles in water
Mono(mPEG)-monoalkyl [Fig. 5 (c)] Good
Di(mPEG)-monoalkyl [Fig. 5 (e)] Poor
Mono(mPEG)-dialkyl [Fig. 5 (f)] Poor

From Examples 2 and 3, it can be concluded that a mono(mPEG)-monoalkyl-substituted surfactant using mPEG with Mn = 5000 has the best ability to disperse nanoparticles in water.
Example 4:Comparison of performance of surfactant for dispersing nanoparticles in waterdepending on original stabilizer of nanoparticles
31P-NMR reveals that the surfactant forms micelles around the nanoparticles - (the same phosphate peaks are found both in water andhexane). This is due to the attraction with the original stabilizer - (the original stabilizerrefers to the stabilizer onthe surface of the nanoparticles.Nanoparticles tend to aggregate because of largesurface energy. The stabilizer stabilizes the surface of the nanoparticles in solvents and thereby preventsaggregation. )- oleic acid, oleylamine or trioctylphosphine oxide (TOPO), which are used to stabilize the alkyl moiety of the surfactant and the nanoparticles in solvents. Accordingly, the versatility of the surfactant depends on the structure of the original stabilizer.
Three commonly used stabilizers oleic acid, oleylamine and TOP/TOPO were tested. In general, oleic acid is used for Pd, Fe2O3 and InP/ZnS nanoparticles, oleylamine is used for Au nanoparticles, and TOP/TOPO is used for CdSe/ZnS nanoparticles. They were synthesized referring to the following literatures [(a) N. R. Jana, Y. Chen and X. Peng, Chem. Mater., 2004, 16, 3931; (b) J. Park, K. An, Y. Hwang, J.-G. Park, H.-J. Noh, J.-Y. Kim, J.-H. Park, N.-M. Hwang and T. Hyeon, Nat. Mater., 2004, 3, 891; (c) F. X. Redl, C. T. Black, G. C. Papaefthymiou, R. L. Sandstorm, M. Yin, H. Zeng, C. B. Murray and S. P. O'Brien, J. Am. Chem. Soc., 2004, 126, 14583]. The individual nanoparticles were transferred from the organic solvent to water in the same manner as Example 2. The result is shown in Fig. 6. Fig. 6 shows that the nanoparticles were successfully transferred from hexane to water. The nanoparticles were dispersed well in water, with no change in physical properties. In case of Fig. 6 (a) and (b), the photoluminescence peak did not change after transfer to water. The quantum yield in water was about 65% of that in hexane. When a surfactant with mPEG 5000 was used, the quantum yield was as high as about 70%.
The quantum yield was calculated from the absorption spectrum and fluorescence spectrum of CdSe/ZnS nanoparticles when they were dispersed in hexane or water. The absorption spectrum was measured using a UV-Vis spectrophotometer, and the fluorescence spectrum was measured using a fluorescence spectrophotometer. Rhodamine 590 was used as a reference organic dye. The quantum yield of the dye in ethanol was 95%. The quantum yield was calculated according to the following equation (Q = quantum yield, A = area under fluorescence peak, I = absorbance at excitation wavelength, n = refractive index of solvent, a = CdSe/ZnS, b = organic dye).
Figure PCTKR2010008588-appb-I000011
The graph inserted in Fig. 6 (c) shows optical absorption of Au nanoparticles in water (red) or in hexane (blue). Both exhibit the same surface plasmon resonance at 530 nm. Fig. 6 (d) shows that Fe2O3 nanoparticles dispersed in water at high concentration exhibits a ferrofluid state and thus is applicable to various fields.
Example 5:Measurement of quantum yield when surfactant for dispersing nanoparticles in water was used
Fe2O3nanoparticles of the same amount (5 equivalents) were mixed in dichloromethane with each of the synthesized surfactants. After completely evaporating the solvent at room temperature for 15 to 20 minutes, the remaining mixture was dispersed again in water. The quantum yield was calculated from the absorption spectrum and fluorescence spectrum of CdSe/ZnS nanoparticles when they were dispersed in hexane or water. The absorption spectrum was measured using a UV-Vis spectrophotometer, and the fluorescence spectrum was measured using a fluorescence spectrophotometer. Rhodamine 590 was used as a reference organic dye. The quantum yield of the dye in ethanol was 95%. The quantum yield was calculated according to the following equation [Q = quantum yield, A = area under fluorescence peak, I = absorbance at excitation wavelength, n = refractive index of solvent, a = CdSe/ZnS, b = organic dye (Rhodamine 590)]. The quantum yield was about 70-80% of that in hexane.
Figure PCTKR2010008588-appb-I000012
When mercaptopropionic acid or phospholipid, which is commonly used to disperse nanoparticles in water, is used, the quantum yield is only about 50% of that in hexanes. In contrast, when the surfactant according to the present disclosure was used, the quantum yield was about 70-80% of that in hexane. This is because the dispersing in water is performed at room temperature without heating.
Example 6:Test of applicability of surfactant for dispersing nanoparticles in water fornanoimaging
In order to test whether the surfactant for dispersing nanoparticles in water according to the present disclosure is applicable to nanobioimaging, hydrated radius was measured by light scattering and gel-filtration chromatography. As seen in Fig. 1, hydrated radius was measured as 12 nm by gel-filtration chromatography, and as 15 nm by light scattering. For nanoimaging, the hydrated radius is a very important factor. For example, in sentinel lymph node mapping, if the hydrated radius is smaller than 5 nm, the nanoparticles diffuse into the blood vessels. If the hydrated radius is 5 to 10 nm, they do not stop at the sentinel lymph node but pass by to the next lymph node. Meanwhile, if the hydrated radius is larger than 300 nm, the nanoparticles cannot move. In MRI imaging, a hydrated radius which is smaller than 30 nm is required for introduction into cells. The hydrated radius is not the simple addition of the size of the nanoparticle with that of the surfactant in water, but depends on relative binding and 3-dimensional structure.
Fig. 7 shows nanoparticles used as an MRI imaging agent dispersed in water using the surfactant according to the present disclosure. It can be seen that the role as the MRI imaging agent is retained. The images are T2-weighted images actually used for clinical diagnosis and treatment, obtained at room temperature with 1.5 T.
The present application contains subject matter related to Korean Patent Application No. 10-2010-0032851, filed in the Korean Intellectual Property Office on April 9, 2010, the entire contents of which is incorporated herein by reference.
Those skilled in the art will appreciate that the conceptions and specific embodiments disclosed in the foregoing description may be readily utilized as a basis for modifying or designing other embodiments for carrying out the same purposes of the present disclosure. Those skilled in the art will also appreciate that such equivalent embodiments do not depart from the spirit and scope of the disclosure as set forth in the appended claims.

The surfactant for dispersing nanoparticles in water according to the present disclosure will to be useful in nanobioimaging applications, for example, as an MRI imaging agent.

Claims (5)

  1. A surfactant for dispersing nanoparticles in water represented by Chemical Formula 1:
    Figure PCTKR2010008588-appb-I000013
    (1)
    wherein n is from 1 to 500; R1 is C1-C30 alkyl; R2 is hydrogen or C1-C50 alkyl; and R3 is hydrogen or C1-C30 alkyl.

  2. The surfactant for dispersing nanoparticles in water according to claim 1, wherein the nanoparticles are gold (Au) nanoparticles, palladium (Pd) nanoparticles, Fe2O3 nanoparticles, Fe3O4 nanoparticles, CdSe nanoparticles, InP/ZnS nanoparticles or CdSe/ZnS nanoparticles.

  3. The surfactant for dispersing nanoparticles in water according to claim 1, wherein, in Chemical Formula 1, n is from 10 to 200; R1 is C1-C5 alkyl; R2 is C1-C20 alkyl; and R3 is C1-C5 alkyl.

  4. A method for preparing a surfactant for dispersing nanoparticles in water represented by Chemical Formula 1, comprising:
    reacting a compound represented by Chemical Formula 2 with a compound represented by Chemical Formula 3 at 10 to 200 ºC for 1 to 24 hours to prepare a compound represented by Chemical Formula 6;
    reacting the resulting compound represented by Chemical Formula 6 with a compound represented by Chemical Formula 4 at 10 to 200 ºC for 0.5 to 48 hours to prepare a compound represented by Chemical Formula 7; and
    reacting the resulting compound represented by Chemical Formula 7 with a compound represented by Chemical Formula 5 at 10 to 200 ºC for 1 to 48 hours:
    Figure PCTKR2010008588-appb-I000014

    wherein n is from 1 to 500; R1 is C1-C30 alkyl; R2 is hydrogen or C1-C30 alkyl; R3 is hydrogen or C1-C30 alkyl; and X is F, Cl, Br or I.

  5. The surfactant for dispersing nanoparticles in water represented by Chemical Formula 1 according to claim 4, wherein, in Chemical Formula 1, n is from 10 to 200; R1 is C1-C5 alkyl; R2 is C1-C20 alkyl; and R3 is C1-C5 alkyl.

PCT/KR2010/008588 2010-04-09 2010-12-02 Surfactants for water dispersing of nanoparticles Ceased WO2011126199A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100032851A KR101076915B1 (en) 2010-04-09 2010-04-09 surfactants for water dispersing of nanoparticles
KR10-2010-0032851 2010-04-09

Publications (1)

Publication Number Publication Date
WO2011126199A1 true WO2011126199A1 (en) 2011-10-13

Family

ID=44763112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/008588 Ceased WO2011126199A1 (en) 2010-04-09 2010-12-02 Surfactants for water dispersing of nanoparticles

Country Status (2)

Country Link
KR (1) KR101076915B1 (en)
WO (1) WO2011126199A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102330638B1 (en) 2020-05-26 2021-11-25 대진대학교 산학협력단 Manufacturing method of silver nanoparticles using auxiliary surfactant
KR102641225B1 (en) * 2021-07-08 2024-02-27 성균관대학교산학협력단 Surfactant and preparing method for the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2971976A (en) * 1959-11-02 1961-02-14 Dow Chemical Co Phosphoroamidothioates
US3666844A (en) * 1968-02-23 1972-05-30 Stauffer Chemical Co Alkylarylpolyoxyalkylene n-hydroxyalkyl phosphoramidates
JPH07228589A (en) * 1994-02-16 1995-08-29 Fuji Photo Film Co Ltd Phosphoric acid ester derivative and silver halide photographic sensitive material

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2971976A (en) * 1959-11-02 1961-02-14 Dow Chemical Co Phosphoroamidothioates
US3666844A (en) * 1968-02-23 1972-05-30 Stauffer Chemical Co Alkylarylpolyoxyalkylene n-hydroxyalkyl phosphoramidates
JPH07228589A (en) * 1994-02-16 1995-08-29 Fuji Photo Film Co Ltd Phosphoric acid ester derivative and silver halide photographic sensitive material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NA, H. B. ET AL.: "Versatile PEG-Derivatized Phosphine Oxide Ligands for Wate r-dispersible Metal Oxide Nanocrystals.", CHEM. COMMUN., 17 October 2007 (2007-10-17), pages 5167 - 5169 *

Also Published As

Publication number Publication date
KR20110113455A (en) 2011-10-17
KR101076915B1 (en) 2011-10-25

Similar Documents

Publication Publication Date Title
Guo et al. Color-tunable Gd-Zn-Cu-In-S/ZnS quantum dots for dual modality magnetic resonance and fluorescence imaging
Wang et al. Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging
Na et al. Versatile PEG-derivatized phosphine oxide ligands for water-dispersible metal oxide nanocrystals
Li et al. Hydrophilic, upconverting, multicolor, lanthanide‐doped NaGdF4 nanocrystals as potential multifunctional bioprobes
Yan et al. Self-assembled magnetic fluorescent polymeric micelles for magnetic resonance and optical imaging
Wang et al. Opportunities and challenges of fluorescent carbon dots in translational optical imaging
JP5569837B2 (en) Method for producing surface-coated inorganic particles
Liu et al. Synthesis of GdAlO3: Mn4+, Ge4+@ Au core–shell nanoprobes with plasmon-enhanced near-infrared persistent luminescence for in vivo trimodality bioimaging
Sitbon et al. Multimodal Mn-doped I–III–VI quantum dots for near infrared fluorescence and magnetic resonance imaging: from synthesis to in vivo application
US9518921B2 (en) Silica nanoparticles with aggregation induced emission characteristics as fluorescent bioprobe for intracellular imaging and protein carrier
US20100119458A1 (en) Compositions Containing Metal Oxide Particles and Their Use
US7598335B2 (en) Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
Zhou et al. A versatile fabrication of upconversion nanophosphors with functional-surface tunable ligands
Hsu et al. Silica nanohybrids integrated with CuInS2/ZnS quantum dots and magnetite nanocrystals: multifunctional agents for dual-modality imaging and drug delivery
JP2010540605A (en) Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilization layer coupled to a hydrophilic biodistributed ligand
Mnasri et al. Design and synthesis of luminescent lanthanide-based bimodal nanoprobes for dual magnetic resonance (MR) and optical imaging
Sun et al. Biocompatible Gd III-functionalized fluorescent gold nanoclusters for optical and magnetic resonance imaging
Benyettou et al. Microwave assisted nanoparticle surface functionalization
CN103013520A (en) Water-soluble near-infrared quantum dot, preparation method and application thereof
US20230142721A1 (en) Composite of Silicate-Based Base Material and Rare-Earth Compound, Light-Emitting Nanoparticle, Cell Detection Method, Treating Method for Treating Non-Human Animal, Medical Device, and Method for Producing Composite of Silicate-Based Base Material and Rare-Earth Compound
WO2011126199A1 (en) Surfactants for water dispersing of nanoparticles
Yan et al. Self-assembled magnetic luminescent hybrid micelles containing rare earth Eu for dual-modality MR and optical imaging
CN109825294B (en) Manganese-doped molybdenum disulfide quantum dot one-step hydrothermal preparation method from bottom to top
Li et al. Effect of surface functionalities on relaxometric properties of MR contrast agents based on NaGdF 4 nanoparticles
KR102500245B1 (en) Fluorescent magnetic nanoparticles using porous silica and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10849546

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10849546

Country of ref document: EP

Kind code of ref document: A1